CHINA FEIHE

6186
2.8102.00% ( +0.055 )
Delay Closed: Nov 16, 16:08:11

Overview

CHINA FEIHE (6186)

China Feihe Limited, an investment holding company, produces and sells dairy products, raw milk, and nutritional supplements in Mainland China, Canada, Indonesi...

Open
2.735
High
2.820
Low
2.730
Prev. Close
2.755
Volume
30.19M
Turnover
84.36M
Avg Price
2.794
Bid/Ask Ratio
-89.74%
Amplitude
3.27%
52wk High
3.908
Volume Ratio
1.60
Turnover Ratio
0.34%
52wk Low
2.145
HK Mkt Cap
24.75B
Market CapHKD
24.75B
P/ETTM
12.10
P/EDynamic
12.84
P/EStatic
--
EPSTTM
0.232
EPSDynamic
0.219
EPSStatic
--
BVPS
3.17
P/B
0.89
HK Shares
8.81B
Dividend YieldTTM
17.88%
DividendTTM
0.5023
Shares
8.81B
Min lot size
1,000
Currency
HKD

CHINA FEIHE Analyst Rating

View more

Forecast & Rating

Oct 29, 2026
Price forecast
HK$3.4823.77%
Forecast & RatingBuy
11analysts
  • Strong buy36.36%
  • Buy18.18%
  • Hold27.27%
  • Sell9.09%
  • Strong sell9.09%

Daily Events

  1. Oct, 16

    China Feihe fell 4.35% to HK$2.420 in a one-way decline, opening lower and fading from an early HK$2.530 high to a 15:46 BJ afternoon low of HK$2.405. The trigger was a RMB 400 million unsecured loan to its controlling shareholder at 2.73% for 'personal financial arrangements' — Citi called it unexpected and rated the stock Sell, while an earlier HKEX censure of a director added to governance and cash-use concerns. The operating picture cuts the other way: Q2 2026 revenue rose 7.85% YoY to HK$5.41 billion, yet net profit fell 11.77% to HK$483 million and EPS slipped 13.75% to HK$0.052. The stock is down 39.95% year-to-date, roughly 46% below its 52-week high of HK$4.48, and trades under its MA20 of HK$2.619 and MA60 of HK$2.895, with PE at 10.4x and PB at 0.76x. The HK$2.56 billion special dividend offers some cushion, though sentiment may stay anchored to governance headlines until the loan's purpose is clarified.

  2. Sep, 30

    China Feihe opened lower but climbed back to close up about 3.02% at HK$2.730, rebounding from HK$2.610 at 09:33 BJ and touching HK$2.745 at 15:27 BJ, driven by its declaration of an HK$2.56 billion special dividend aimed at shoring up investor confidence. Fundamentals stay mixed: Q2 2026 revenue rose 7.89% YoY to HK$5.40 billion, yet net profit fell 11.74% to HK$483 million and EPS dropped 13.72% to HK$0.0519, with the net margin at 8.94%. Valuation sits at 11.76x PE, 0.86x PB and a 7.76% dividend yield; the shares hold above the HK$2.608 MA20 but remain under the HK$2.98 MA60, down 32.26% year-to-date and 39.06% below the HK$4.48 52-week high, only 12.11% above the HK$2.435 low of 15 September. A HKEX censure of a non-executive director had earlier pushed the stock to a record low, and UBS and BofAS cut their targets to HK$3.2 and HK$2.4 respectively, though the special dividend and Huatai Securities' unchanged rating cushioned sentiment.

  3. Sep, 11

    China Feihe (6186.HK) closed at 2.575 HKD, up 2.0% from previous close of 2.525 HKD, staging a recovery from intraday low of 2.480 HKD during morning session (a new 52-week low) before rebounding to an afternoon high of 2.530 HKD. The early weakness stemmed from accumulating bearish catalysts: Q2 2026 net profit fell 11.7% YoY to 483 million HKD with a 31.5% interim dividend cut, prompting Citi to downgrade to Sell (target cut to 2.5 HKD), BofAS to Underperform (2.4 HKD target), and UBS to cut target to 3.2 HKD; additionally, non-executive director Gao Yu faced HKEX censure over governance issues. However, top-line remained resilient with revenue up 7.9% YoY to 5.4 billion HKD and net margin stable at ~8.9%. The stock is down 36.1% YTD from its 2026 open at 4.03 HKD, trading well below MA20 (2.944) and MA60 (3.060), with a 42.5% discount to 52-week high of 4.48 HKD, though PB of 0.81x offers some value support.

  4. Sep, 9

    China Feihe opened lower and continued to decline in the afternoon session, closing at HKD 2.615, down 4.04% on the day, driven by disappointing interim results released last week showing a double-digit net profit decline and a reduced interim dividend. Q2 net profit fell 11.74% YoY to approximately HKD 483 million, with operating profit down 6.85% YoY, despite a 7.89% rise in revenue. Multiple brokerages have cut their target prices following the results. The stock has hit a new 52-week low and sits 41.63% below its November 2025 high of HKD 4.48, well below its 20-day and 60-day moving averages of HKD 3.016 and HKD 3.077, respectively. However, a PB ratio of 0.82x and a high dividend yield of 8.10% may provide some downside cushion.

  5. Aug, 31

    China Feihe opened lower and continued to decline, closing down 3.28% at HKD 2.805, hitting a 52-week low intraday at HKD 2.805, with total volume of 30.41 million shares and turnover of HKD 85.76 million. The price weakness was primarily driven by earnings disappointment: Q2 revenue rose 7.89% YoY to HKD 5.40 billion, but net profit fell 11.74% YoY to HKD 483 million, with a net margin of only 8.94% and EPS down 13.73% YoY to HKD 0.0519, while the interim dividend was cut by 31.5%. On the news front, Citi downgraded the stock to Sell with a target price cut to HKD 2.5, and BofA Securities also downgraded to Underperform with a target price of HKD 2.4. The stock now trades 39.55% below its 52-week high of HKD 4.64 and well below both its 20-day MA (HKD 3.189) and 60-day MA (HKD 3.12), with a YTD decline of 30.4%. However, the PE of 12.08x and PB of 0.88x are relatively low, and the dividend yield remains at 9.04%.

News

Bullish vs. Bearish — Last 3 Months

4.1k followers · 0 opinions
▲Bullish50%
50%Bearish▼
  • M
    momoM

    $CHINA FEIHE(06186.HK) feels like Hong Kong tech stocks are stagnating, so I switched to consumer stocks. I bought Feihe because the chart looked tight, but didn't expect a policy announcement today.

    图片 1,共 1 张